Academic · Private company
HonorHealth Research Institute
Track this companyFree. Adds HonorHealth Research Institute to your Dealase workspace and tells you when its record changes.
Clinical trials201 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials20
- Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal CarcinomaPHASE1_PHASE2 · RECRUITING · started Feb 17, 2026ClinicalTrials.gov NCT07463599 · fetched Nov 12, 2026
- The Seven Trial: Exploiting the Unfolded Protein ResponsePHASE1 · TERMINATED · started Jan 9, 2025ClinicalTrials.gov NCT06076837 · fetched Nov 12, 2026
- Lurbinectedin in Patients With Advanced Gastrointestinal Malignancies With DNA Repair MutationsPHASE2 · COMPLETED · started Jun 14, 2022ClinicalTrials.gov NCT05229588 · fetched Nov 12, 2026
- Pemigatinib in Subjects With Adenosquamous Carcinoma of the PancreasPHASE2 · WITHDRAWN · started Jun 14, 2022ClinicalTrials.gov NCT05216120 · fetched Nov 12, 2026
- Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal MelanomaPHASE1 · COMPLETED · started Feb 28, 2022ClinicalTrials.gov NCT05004025 · fetched Nov 12, 2026
- Pilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic CancersPHASE1 · WITHDRAWN · started Dec 31, 2021ClinicalTrials.gov NCT04611139 · fetched Nov 12, 2026
- Inhaled IAV vs Inhaled Eucalyptus for the Treatment of Nausea With Acute MigraineNA · COMPLETED · started Nov 11, 2021ClinicalTrials.gov NCT05175521 · fetched Nov 12, 2026
- Phase II Trial of Vemurafenib and Sorafenib in Pancreatic CancerPHASE2 · COMPLETED · started Oct 28, 2021ClinicalTrials.gov NCT05068752 · fetched Nov 12, 2026
- Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydroxychloroquine as Treatment in Untreated Pancreas CancerPHASE2 · COMPLETED · started Dec 1, 2020ClinicalTrials.gov NCT04669197 · fetched Nov 12, 2026
- Atovaquone and Azithromycin Combination for Confirmed COVID-19 InfectionPHASE2 · TERMINATED · started Apr 20, 2020ClinicalTrials.gov NCT04339426 · fetched Nov 12, 2026
- Hair Loss Prevention Study for Pancreatic CancerNA · COMPLETED · started Dec 13, 2019ClinicalTrials.gov NCT04492800 · fetched Nov 12, 2026
- Disulfiram-Copper Gluconate in Met Pancreas Cancer w Rising CA19-9 on Abraxane-Gemzar, FOLFIRINOX or GemcitabinePHASE2 · TERMINATED · started Oct 17, 2019ClinicalTrials.gov NCT03714555 · fetched Nov 12, 2026
- Prospective Analysis of the Use of N-Acetylcysteine and Vitamins in the Treatment of TBI in Geriatric PatientsPHASE2 · COMPLETED · started Sep 1, 2019ClinicalTrials.gov NCT04291066 · fetched Nov 12, 2026
- Nab-Paclitaxel + Cisplatin + Gemcitabine in Untreated Metastatic Pancreatic AdenocarcinomaPHASE2 · COMPLETED · started Jul 15, 2019ClinicalTrials.gov NCT03915444 · fetched Nov 12, 2026
- SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance and Dual Anti-Platelet TherapyPHASE2 · TERMINATED · started Nov 19, 2018ClinicalTrials.gov NCT03606642 · fetched Nov 12, 2026
- Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD)PHASE2 · COMPLETED · started Jan 31, 2018ClinicalTrials.gov NCT03415854 · fetched Nov 12, 2026
- Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM)PHASE1_PHASE2 · COMPLETED · started Dec 15, 2017ClinicalTrials.gov NCT03410030 · fetched Nov 12, 2026
- Pre-operative Treatment for Patients With Untreated Pancreatic CancerPHASE2 · COMPLETED · started May 23, 2017ClinicalTrials.gov NCT03138720 · fetched Nov 12, 2026
- Hand Therapy Intervention Versus Traditional Occupational Therapy to Prevent Chemotherapy Induced Peripheral NeuropathyNA · COMPLETED · started May 13, 2016ClinicalTrials.gov NCT05374876 · fetched Nov 12, 2026
- Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal AdenocarcinomaPHASE2 · COMPLETED · started Apr 1, 2016ClinicalTrials.gov NCT02754726 · fetched Nov 12, 2026